Liu YC - Search Results

1

IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis.

Chu PY, Huang WC, Tung SL, Tsai CY, Chen CJ, Liu YC, Lee CW, Lin YH, Lin HY, Chen CY, Yeh CT, Lin KH, Chi HC. Chu PY, et al. Among authors: liu yc. Cell Biosci. 2022 Aug 8;12(1):124. doi: 10.1186/s13578-022-00858-8. Cell Biosci. 2022. PMID: 35941699 Free PMC article.

2

Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis.

Liu YC, Yeh CT, Lin KH. Liu YC, et al. Int J Mol Sci. 2019 Oct 9;20(20):4986. doi: 10.3390/ijms20204986. Int J Mol Sci. 2019. PMID: 31600974 Free PMC article. Review.

3

Hepatitis B Virus X Protein Induces RHAMM-Dependent Motility in Hepatocellular Carcinoma Cells via PI3K-Akt-Oct-1 Signaling.

Liu YC, Lu LF, Li CJ, Sun NK, Guo JY, Huang YH, Yeh CT, Chao CC. Liu YC, et al. Mol Cancer Res. 2020 Mar;18(3):375-389. doi: 10.1158/1541-7786.MCR-19-0463. Epub 2019 Dec 2. Mol Cancer Res. 2020. PMID: 31792079

4

Correction: Lin, K.-H., et al. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis. Int. J. Mol. Sci., 2019, 20, 4986.

Liu YC, Yeh CT, Lin KH. Liu YC, et al. Int J Mol Sci. 2020 Apr 30;21(9):3185. doi: 10.3390/ijms21093185. Int J Mol Sci. 2020. PMID: 32366022 Free PMC article.

5

Reply to Comments: "Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis" Int. J. Mol. Sci., 2019, 20, 4986.

Liu YC, Yeh CT, Lin KH. Liu YC, et al. Int J Mol Sci. 2020 May 19;21(10):3554. doi: 10.3390/ijms21103554. Int J Mol Sci. 2020. PMID: 32438653 Free PMC article.

6

Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.

Liu YC, Yeh CT, Lin KH. Liu YC, et al. Cells. 2020 May 26;9(6):1331. doi: 10.3390/cells9061331. Cells. 2020. PMID: 32466488 Free PMC article. Review.

7

Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.

Liao WC, Lin TJ, Liu YC, Wei YS, Chen GY, Feng HP, Chang YF, Chang HT, Wang CL, Chi HC, Wang CI, Lin KH, Ou Yang WT, Yu CJ. Liao WC, et al. Among authors: liu yc. Cancer Sci. 2022 Jan;113(1):205-220. doi: 10.1111/cas.15197. Epub 2021 Nov 25. Cancer Sci. 2022. PMID: 34773335 Free PMC article.

8

CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.

Liu YC, Lin YH, Chi HC, Huang PS, Liao CJ, Liou YS, Lin CC, Yu CJ, Yeh CT, Huang YH, Lin KH. Liu YC, et al. Clin Epigenetics. 2022 Aug 23;14(1):106. doi: 10.1186/s13148-022-01326-3. Clin Epigenetics. 2022. PMID: 35999564 Free PMC article.

9

LPAL2 Suppresses Tumor Growth and Metastasis of Hepatocellular Carcinoma by Modulating MMP9 Expression.

Lin YH, Liu YC, Chen CY, Chi HC, Wu MH, Huang PS, Chang CC, Lin TK, Yeh CT, Lin KH. Lin YH, et al. Among authors: liu yc. Cells. 2022 Aug 22;11(16):2610. doi: 10.3390/cells11162610. Cells. 2022. PMID: 36010685 Free PMC article.

10

Inhibition of JNK and prothymosin-alpha sensitizes hepatocellular carcinoma cells to cisplatin.

Lin YT, Liu YC, Chao CC. Lin YT, et al. Among authors: liu yc. Biochem Pharmacol. 2016 Dec 15;122:80-89. doi: 10.1016/j.bcp.2016.10.003. Epub 2016 Oct 14. Biochem Pharmacol. 2016. PMID: 27751820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,645 results

Search Page

Filters